-
-
-
-
Description
- 12-mer peptide
-
Activity
- Antibacterial(bacterial membranes)
-
Target Organism
-
- Gram-negative bacteria:
E. coli J5 (MIC90=0.003X10-6 M), E. coli J96 (MIC90=0.25X10-6 M), E. coli H5 (MIC90=0.08X10-6 M), E. coli IA2 (MIC90=0.08X10-6 M), Pseudomonas aeruginosa (MIC90=0.01X10-6 M); - Gram-positive bacteria:
Staphlococcus aureus MN8 (MIC90=0.35X10-6 M), Staphlococcus aureus MNHO (MIC90=0.4X10-6 M).
-
Reference
-
- Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. (2006)
- Design of a potent novel endotoxin antagonist. Surgery(1997).(PMID: 9288144)
-
Medical use
- Broad-spectrum antimicrobial;Antiendotoxin
-
-
Stage of Development
- Preclinical
-
- In addition to targeting bacterial membranes, PTX002 and PTX005 neutralise endotoxin in the blood and may prove effective in treating sepsis.Preliminary studies in mouse infection models, using a lethal dose of P. a e r u g i n o s a, showed a fivefold increase in survival in treated animals (71%) compared with control animals (14%).
-